Pretreatment of HL60 cells with Deoxyspergualin enhances trail-induced apoptosis independent of caspase 3 activation.
Wu
J
J
Division of Immunobiology, Department of Surgery at The University of Alabama at Birmingham, Birmingham, Alabama, USA.
He
J
J
Sooudi
S
S
Jiang
X L
XL
Ray
P
P
Thomas
F
F
Thomas
J M
JM
D017209:Apoptosis / Q000187:drug effects*; D051017:Apoptosis Regulatory Proteins; D053148:Caspase 3; D020169:Caspases / Q000378:metabolism; D004789:Enzyme Activation; D006146:Guanidines / Q000494:pharmacology*; D018922:HL-60 Cells / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D008024:Ligands; D008562:Membrane Glycoproteins / Q000494:pharmacology*; D053221:TNF-Related Apoptosis-Inducing Ligand; D023001:Transplantation Tolerance; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D051017:Apoptosis Regulatory Proteins; D006146:Guanidines; D007166:Immunosuppressive Agents; D008024:Ligands; D008562:Membrane Glycoproteins; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; D014409:Tumor Necrosis Factor-alpha; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases; C037258:gusperimus